	Efficacy of Heartfulness Meditation as Adjunctive Therapy for Moderate to Severe Psoriasis: A Randomised Controlled Trial. Indian J Dermatol Nagendran P, Subramanian SK, Satyanarayanan, Sripad VD, Rajendran R, Gopinath H, Sravanthi KL, Thiruveedhula H. PMID: 42555361 [PubMed]
	INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management. J Drugs Dermatol Issa NT, Lebwohl M, Chovatiya R, Kircik L. PMID: 42555081 [PubMed - indexed for MEDLINE]
	Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol. J Drugs Dermatol Alqefari AN, Almutairi HM, Almohaimeed MY, Aldossari AA, Alqefari G, Alsaleam A, Alzolibani AA, Alhameedy M. PMID: 42555076 [PubMed - indexed for MEDLINE]
	Improved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study. J Drugs Dermatol De Luca DA, Papara C, Pommerien L, Hawro T, Thaçi D. PMID: 42555075 [PubMed - indexed for MEDLINE]
	Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis. J Drugs Dermatol Shami MZ, Amara S, Shimon SV, Kest I, Islam RK, Moffatt L, Lebwohl M. PMID: 42555067 [PubMed - indexed for MEDLINE]
	Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis. J Drugs Dermatol Fong S, Flamm A, Zampella JG. PMID: 42555065 [PubMed - in process]
	Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort. J Drugs Dermatol Adler R, Gandhi I, Edwards T, Svigos K, Jakus J. PMID: 42555064 [PubMed - in process]
	Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study. J Drugs Dermatol Garfinkel V, Feron H, Nezafati K. PMID: 42555063 [PubMed - in process]
	Association Between Psoriasis and Overactive Bladder Among US Adults: A Study Based on 2005-2006 and 2009-2014 National Health and Nutrition Examination Survey. Neurourol Urodyn Zhuo X, Wang J, Wang X, Wen P. PMID: 42554142 [PubMed - as supplied by publisher]
	Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol. Front Med (Lausanne) Hu J, Long D, Chen J, Luo M, Zhou R, Zhang X, Lei Z, Deng W, Kuang Y, Wang H. PMID: 42553580 [PubMed]
	Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis. Expert Opin Pharmacother McGuirt V, Razler D, Moore SG, Feldman S. PMID: 42552595 [PubMed - as supplied by publisher]
	Mechanistic insight into Solanum lyratum extract for ameliorating imiquimod-induced psoriasis in mice via suppression of mast cells and Th17 cell response. Fitoterapia Jin S, Chen J, He Y, Guo Y, Zhang J, Zhang Z, Ye F, Chen G. PMID: 42551598 [PubMed - as supplied by publisher]
	Patients with Psoriatic Arthritis Have Increased Dental Comorbidities: A Nationwide Population-based Cohort Study in Korea. Acta Derm Venereol Kong S, Kim KE, Kwak EJ, Kim HN, Kim A, Jeon J, Park CM, Baek YS. PMID: 42549605 [PubMed - indexed for MEDLINE]
	Diagnostic Usefulness of Immunohistochemical Staining for EMA in Psoriasis and Atopic Dermatitis Showing Psoriasiform Hyperplasia. Ann Dermatol Jeong SM, Kim HJ, Son CH, Park JB, Suh KS, Jang MS. PMID: 42547482 [PubMed]
	The Definition of Psoriasis Severity and Treatment Target of Psoriasis: Korean Expert Consensus Using the Modified Delphi Method. Ann Dermatol Bang CH, Baek YS, Kim TG, Jeong KH, Kim JE, Jo SJ, Lee ES, Choe YB, Korean Society for Psoriasis. PMID: 42547478 [PubMed]
	Factors Associated With PASI90 Maintenance Without Flare-Up and Predictors of Biologics Discontinuation in Psoriasis: Two-Center Retrospective Cohort Study in Korea. Ann Dermatol Choi MS, Yeom K, Jung SW, Hong SP, Kong KA, Kim MH. PMID: 42547477 [PubMed]
	Real-World Effectiveness and Safety of Deucravacitinib for Plaque Psoriasis: A Multicenter Study in Korea. Ann Dermatol Shin BS, Kim BS, Lee GJ, Seong J, Kim G, Gwack J, Nam KH. PMID: 42547476 [PubMed]
	Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study. BioDrugs Ma X, Jiang Y, Liu D, Xu Q, Shen F, Duan Z, Gao X, Zhang X, Cai R, Zhang R, Li B, Wang R. PMID: 42545602 [PubMed - as supplied by publisher]
	Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group). Psoriasis (Auckl) Daudén E, De la Cueva P, Belinchón I, Gallardo F, Coto P, Ruiz-Villaverde R, Poveda JL, Ramirez E, Colominas E, Ros S, Alfonso S, López-Pérez D, Comellas M. PMID: 42544342 [PubMed]
	Hepatic Steatosis in Biologic-Treated Patients With Psoriasis and Low Current Disease Activity: Prevalence and Metabolic Determinants. J Dermatol Ding L, Chen J, Dong X. PMID: 42543704 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28346

Page 1 of 1418



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy